Overview

Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was to determine whether a single intramuscular injection of dexamethasone decreased the duration of symptoms of acute bronchiolitis in young children.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Khon Kaen University
Collaborator:
National Research Council of Thailand
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Criteria
Inclusion Criteria:

- Aged 4 weeks - 24 months

- Has the first episode of wheezing within 7 days

- Has evidence of viral infection

- Requires hospital admission; criteria for admission include one of the following: age
< 3 months; respiratory rate > 60 breaths/minute for age < 12 months or 50
breaths/minute for > or equal to 12 months; oxygen saturation in room air < 95% and
apathy or refuses feeding.

Exclusion Criteria:

- Initial admission to intensive care unit

- Initial requirement for endotracheal intubation or mechanical ventilation

- A previous history of intubation

- A known history of asthma or response to the first dose of beta2 agonist nebulization

- A history of prematurity

- A history of bronchopulmonary dysplasia or chronic lung disease

- Underlying congenital heart disease or immunodeficiency

- Receives treatment of any form of corticosteroids within 2 weeks

- Has contraindication to corticosteroid treatment